SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of SB-715992 in treating patients who have acute
leukemia, chronic myelogenous leukemia, or advanced myelodysplastic syndromes. Drugs used in
chemotherapy, such as SB-715992, work in different ways to stop cancer cells from dividing so
they stop growing or die